Skip to content

Market explorer

Screen the results we have checked

Search and filter our published results. This is selected coverage, not a screen of every listed stock.

Read the basis before comparing. Revenue is the company's reported revenue line, not a standardised comparable measure. Excise, acquisitions, exceptional items and different reporting periods can change growth. Missing revenue or growth is not zero. Each result below keeps its filing basis and caveats. No live prices, valuation filters or recommendations.

1 matching results out of 156 published entries. 69 have revenue growth available.

PI Industries

Growth unavailable

Q2 FY2027 · Period ended 30 Sep 2026

Basis: Consolidated unaudited results approved 4 Nov 2026; limited review

Reported revenue (₹ million, except EPS in ₹): 17,018

Read summary and comparison caveats

PI Industries reported consolidated September-quarter revenue from operations of ₹17,018 million versus ₹18,723 million a year earlier. Profit before tax was ₹1,840 million versus ₹5,253 million, and profit for the period was ₹1,222 million versus ₹4,093 million. No exceptional item is printed for either quarter.

  • The full 15-page own-site-linked document was read, including separate standalone and consolidated statements, notes, cash flows, segment information and review reports. Consolidated figures on PDF page 7 are used here; amounts remain in rupees million without conversion. Comparisons are with the quarter ended 30 Sep 2025, not the half year. Key statement, notes, cash-flow and segment pages were also inspected visually because the text layer misreads some digits.
  • Standalone revenue of ₹15,335 million and profit of ₹2,071 million are not substituted for consolidated revenue or profit. The consolidated statement includes the ₹35 million share of profit of the associate and joint venture before tax. Total comprehensive income is separate from profit for the period, and EPS is not annualised.
  • Annexure I reports agro-chemicals segment revenue of ₹16,280 million and pharma revenue of ₹759 million before ₹21 million intersegment elimination. Segment pre-tax results are ₹2,473 million for agro chemicals and a ₹601 million loss for pharma, with a negative ₹32 million intersegment adjustment. These are segment results, not separate group-profit figures.
  • The ₹1,260 million contingent-consideration write-back and ₹229 million labour-code expense in the consolidated notes relate to the year ended 31 Mar 2026. They are not current-quarter exceptional items. The separate standalone investment provision is not a consolidated-quarter charge.
  • Consolidated operating cash inflow of ₹8,899 million versus ₹2,476 million covers six months. It is not quarterly profit or quarterly cash flow. The consolidated group includes subsidiaries, a controlled trust, associate and joint venture, including the joint venture subsidiary from 3 Jul 2026.
  • Price Waterhouse gives an unmodified limited-review conclusion, not an audit opinion. It relies on other auditors for certain entities and on management-provided unreviewed results for four subsidiaries judged immaterial to the group; the conclusion is not modified for those matters.
  • Original source-attributed factual summary, not a forecast, recommendation or completeness claim. Current exposed disclaimer, privacy and security policies were checked; trademark restrictions and the separate QIP-document restrictions are not treated as a general financial-results reuse licence or a general prohibition. No explicit restriction on a short factual financial summary was found in the checked corporate pages. No calculated growth or unprinted QoQ is added.

Checked 19 Nov 2026

Open original filing
Read the complete published results desk